PMA supplement
P080003 S009: Envision Mammography Platform
FDA PMA supplement · Normal 180 Day Track · Hologic, Inc.
Key facts
| Original PMA | P080003 |
|---|---|
| Supplement number | S009 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | Envision Mammography Platform |
| Generic name | Digital breast tomosynthesis |
| Applicant | Hologic, Inc. |
| Product code | OTE |
| Received date | Aug 31, 2023 |
| Decision date | Jul 5, 2024 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: